173 filings
SC 13G
MDNAF
Medicenna Therapeutics Corp.
10 May 24
Medicenna Therapeutics / RA CAPITAL MANAGEMENT ownership change
5:52pm
POS AM
MDNAF
Medicenna Therapeutics Corp.
10 May 24
Prospectus update (post-effective amendment)
4:05pm
6-K
MDNAF
Medicenna Therapeutics Corp.
30 Apr 24
Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management
3:07pm
6-K
MDNAF
Medicenna Therapeutics Corp.
26 Apr 24
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
3:28pm
6-K
MDNAF
Medicenna Therapeutics Corp.
25 Apr 24
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
2:00pm
AW
MDNAF
Medicenna Therapeutics Corp.
22 Apr 24
Withdrawal of amendment
4:40pm
S-8 POS
MDNAF
Medicenna Therapeutics Corp.
16 Apr 24
Registration of securities for employees (post-effective amendment)
5:05pm
F-3/A
MDNAF
Medicenna Therapeutics Corp.
16 Apr 24
Shelf registration (foreign) (amended)
5:05pm
F-10POS
MDNAF
Medicenna Therapeutics Corp.
16 Apr 24
Automatic registration of securities (post-effective amendment, Canada)
5:04pm
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Apr 24
Current report (foreign)
8:44pm
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Apr 24
Current report (foreign)
2:05pm
6-K
MDNAF
Medicenna Therapeutics Corp.
4 Apr 24
Medicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
2:00pm
6-K
MDNAF
Medicenna Therapeutics Corp.
6 Mar 24
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
11:00am
SC 13G/A
Merchant Fahar
21 Feb 24
Medicenna Therapeutics / Merchant Fahar ownership change
8:26pm
6-K
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
6-K
MDNAF
Medicenna Therapeutics Corp.
13 Feb 24
Current report (foreign)
10:30am
SC 13G/A
MDNAF
Medicenna Therapeutics Corp.
7 Feb 24
Medicenna Therapeutics / HIRSCHMAN ORIN ownership change
6:55pm
6-K
MDNAF
Medicenna Therapeutics Corp.
24 Jan 24
Notice of Change of Auditor
4:00pm
6-K
MDNAF
Medicenna Therapeutics Corp.
12 Jan 24
Medicenna Announces Appointment of New Auditor
7:15pm
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Jan 24
Medicenna Commences Enrollment in the ABILITY-1 Study Combining MDNA11 with Pembrolizumab
10:33am